GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » NeoPharm Co Ltd (XKRX:092730) » Definitions » Cyclically Adjusted PB Ratio

NeoPharm Co (XKRX:092730) Cyclically Adjusted PB Ratio : 2.14 (As of May. 21, 2024)


View and export this data going back to 2007. Start your Free Trial

What is NeoPharm Co Cyclically Adjusted PB Ratio?

As of today (2024-05-21), NeoPharm Co's current share price is ₩26950.00. NeoPharm Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was ₩12,591.00. NeoPharm Co's Cyclically Adjusted PB Ratio for today is 2.14.

The historical rank and industry rank for NeoPharm Co's Cyclically Adjusted PB Ratio or its related term are showing as below:

XKRX:092730' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.63   Med: 4.73   Max: 13.06
Current: 2.09

During the past years, NeoPharm Co's highest Cyclically Adjusted PB Ratio was 13.06. The lowest was 1.63. And the median was 4.73.

XKRX:092730's Cyclically Adjusted PB Ratio is ranked worse than
66.11% of 1263 companies
in the Consumer Packaged Goods industry
Industry Median: 1.34 vs XKRX:092730: 2.09

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

NeoPharm Co's adjusted book value per share data for the three months ended in Mar. 2024 was ₩20,491.015. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₩12,591.00 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


NeoPharm Co Cyclically Adjusted PB Ratio Historical Data

The historical data trend for NeoPharm Co's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NeoPharm Co Cyclically Adjusted PB Ratio Chart

NeoPharm Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.19 4.09 2.93 1.87 2.12

NeoPharm Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.69 2.32 2.16 2.12 1.95

Competitive Comparison of NeoPharm Co's Cyclically Adjusted PB Ratio

For the Household & Personal Products subindustry, NeoPharm Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NeoPharm Co's Cyclically Adjusted PB Ratio Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, NeoPharm Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where NeoPharm Co's Cyclically Adjusted PB Ratio falls into.



NeoPharm Co Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

NeoPharm Co's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=26950.00/12591
=2.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NeoPharm Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, NeoPharm Co's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=20491.015/118.8477*118.8477
=20,491.015

Current CPI (Mar. 2024) = 118.8477.

NeoPharm Co Quarterly Data

Book Value per Share CPI Adj_Book
201406 4,344.630 99.353 5,197.118
201409 4,340.653 99.608 5,179.068
201412 4,402.517 99.098 5,279.915
201503 4,432.383 99.720 5,282.576
201506 0.000 100.050 0.000
201509 0.000 100.110 0.000
201512 4,611.448 100.220 5,468.569
201603 0.000 100.560 0.000
201606 5,018.460 100.790 5,917.575
201609 5,277.672 101.460 6,182.133
201612 5,452.101 101.560 6,380.166
201703 5,555.006 102.850 6,419.054
201706 5,990.517 102.610 6,938.497
201709 6,317.512 103.490 7,255.018
201712 6,725.834 102.990 7,761.432
201803 6,827.794 104.100 7,795.078
201806 7,345.991 104.130 8,384.271
201809 7,746.174 105.650 8,713.819
201812 8,380.413 104.350 9,544.732
201903 8,421.841 104.490 9,579.064
201906 12,230.555 104.880 13,859.395
201909 12,757.025 105.200 14,412.006
201912 13,514.591 105.120 15,279.472
202003 13,445.924 105.540 15,141.341
202006 14,022.971 104.870 15,892.036
202009 14,399.674 106.200 16,114.578
202012 15,052.182 105.765 16,914.012
202103 15,157.385 107.357 16,779.688
202106 15,673.276 107.579 17,315.087
202109 16,058.190 108.759 17,547.747
202112 16,661.693 109.676 18,054.968
202203 16,591.529 111.806 17,636.519
202206 17,195.548 114.083 17,913.755
202209 17,704.094 114.831 18,323.322
202212 18,184.060 115.200 18,759.809
202303 18,337.700 116.550 18,699.279
202306 19,066.885 117.140 19,344.864
202309 19,692.755 119.111 19,649.190
202312 20,462.029 118.848 20,462.029
202403 20,491.015 118.848 20,491.015

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


NeoPharm Co  (XKRX:092730) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


NeoPharm Co Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of NeoPharm Co's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


NeoPharm Co (XKRX:092730) Business Description

Traded in Other Exchanges
N/A
Address
928 Tamnip-dong, Yuseong-gu, Daejon, KOR, 305-510
NeoPharm Co Ltd is a South Korean company operating in the household and personal products. The products of the company include skin care brand, skin barrier special dermo cosmetic brand, hospital functional products, and life moisturizing body professional brand.

NeoPharm Co (XKRX:092730) Headlines

No Headlines